Email updates

Keep up to date with the latest news and content from Arthritis Research & Therapy and BioMed Central.

Download references

This article is part of the supplement: Proceedings of the 8th Global Arthritis Research Network (GARN) Meeting and 1st Bio-Rheumatology International Congress (BRIC)

AJAK inhibitor, tofacitinibreduces IL-6 and matrix metalloproteinase-3 productionin rheumatoid arthritis with suppressed cartilage destruction

Kunihiro Yamaoka*, Satoshi Kubo, Koshiro Sonomoto, Keisuke Maeshima and Yoshiya Tanaka

  • * Corresponding author: Kunihiro Yamaoka

Arthritis Research & Therapy 2012, 14(Suppl 1):P77  doi:10.1186/ar3678

Include


Format